BMB Reports : eISSN 1976-670X

Cited by CrossRef (6)

  1. Ying-Xue Zhang, Feng-Xia Sun, Xiao-Ling Li, Qing-Hua Liu, Zi-Meng Chen, Yu-Fei Guo. Identification of Molecular Subgroups in Liver Cirrhosis by Gene Expression Profiles. Hepat Mon 2022;21
    https://doi.org/10.5812/hepatmon.118535
  2. Dandan Tang, Qing Zhang, Huxinyue Duan, Xun Ye, Jia Liu, Wei Peng, Chunjie Wu, Cristina Angeloni. Polydatin: A Critical Promising Natural Agent for Liver Protection via Antioxidative Stress. Oxidative Medicine and Cellular Longevity 2022;2022:1
    https://doi.org/10.1155/2022/9218738
  3. Byeonggeun Kang, Byunghee Kang, Tae-Young Roh, Rho Hyun Seong, Won Kim. The Chromatin Accessibility Landscape of Nonalcoholic Fatty Liver Disease Progression. Mol.Cells 2022;45:343
    https://doi.org/10.14348/molcells.2022.0001
  4. Si-Cho Kim, Jiwon Kim, Da-Won Kim, Yanghee Choi, Kyunghyun Park, Eun Ju Cho, Su Jong Yu, Jeongsil Kim-Ha, Young-Joon Kim. Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples. BMB Rep 2022;55:553
    https://doi.org/10.5483/BMBRep.2022.55.11.110
  5. Mengqin Yuan, Xue Hu, Lichao Yao, Pingji Liu, Yingan Jiang, Lanjuan Li. Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis. Front. Mol. Biosci. 2022;9
    https://doi.org/10.3389/fmolb.2022.1010160
  6. María Arechederra, Miriam Recalde, María Gárate-Rascón, Maite G. Fernández-Barrena, Matías A. Ávila, Carmen Berasain. Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease. Cancers 2021;13:1265
    https://doi.org/10.3390/cancers13061265